Global Biotechnologies, Inc. FDA Inspection Record

FEI 3000717683 · Inspections, Form 483s, warning letters and import refusals

Global Biotechnologies, Inc. is an FDA-inspected facility (FEI 3000717683) located in Portland, ME, US. RegDataLab tracks 6 FDA inspections and 2 compliance actions at this facility.

What FDA found at this site

Latest inspection
Jun 18, 2026: No Action Indicated (NAI)
Inspections on record
6 (5 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
1 listed by FDA for this FEI, latest Aug 21, 2012

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 18, 2026No Action Indicated (NAI)No citations listed
Apr 13, 2023Voluntary Action Indicated (VAI)Batch record - every batch (21 CFR 111.255(a))
Batch record - date, time; maintenance (21 CFR 111.260(c))
Master manufacturing record - each batch (21 CFR 111.205(a))
Sep 6, 2019Voluntary Action Indicated (VAI)Written procedures, laboratory operations (21 CFR 111.325(a))
Master manufacturing record theoretical and expected yield (21 CFR 111.210(f))
Records - material review, disposition documentation (21 CFR 111.140(b)(3))
Sanitary facilities and controls (21 CFR 117.37)
Sep 30, 2016Voluntary Action Indicated (VAI)Personnel - quality control operations; responsibilities (21 CFR 111.12(b))
Packaging description, representative label (21 CFR 111.210(g))
Mar 18, 2013Voluntary Action Indicated (VAI)Batch record - every batch (21 CFR 111.255(a))
Batch record - follow master (21 CFR 111.255(c))
Batch record - identifier; labels (21 CFR 111.260(k)(1))
Written procedures - holding (21 CFR 111.453)
Mar 16, 2012Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Product flow through building is inadequate (21 CFR 211.42(b))
Actual vs. theoretical yields not determined (21 CFR 211.103)
Written procedures - cleaning (21 CFR 111.16)
and 21 more

FDA record score

5 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIApr 13, 20236 x 0.63.6
Inspection classified VAISep 6, 20196 x 0.251.5
Inspection classified VAISep 30, 201610 years or older, so it adds no points0
Inspection classified VAIMar 18, 201310 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsAug 21, 201210 years or older, so it adds no points0
Inspection classified VAIMar 16, 201210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Global Biotechnologies, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Global Biotechnologies, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Global Biotechnologies, Inc.
Location
Portland, ME (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.